169 related articles for article (PubMed ID: 38001596)
1. Risk of Second Tumors in Retinoblastoma Survivors after Ionizing Radiation: A Review.
Figueiredo D; Marques IA; Pires AS; Cavaleiro CF; Costa LC; Castela G; Murta JN; Botelho MF; Abrantes AM
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001596
[TBL] [Abstract][Full Text] [Related]
2. Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapy.
Chaussade A; Millot G; Wells C; Brisse H; Laé M; Savignoni A; Desjardins L; Dendale R; Doz F; Aerts I; Jimenez I; Cassoux N; Stoppa Lyonnet D; Gauthier Villars M; Houdayer C
Eur J Med Genet; 2019 Mar; 62(3):217-223. PubMed ID: 30031154
[TBL] [Abstract][Full Text] [Related]
3. Subsequent Malignant Neoplasms in Retinoblastoma Survivors.
Fabius AWM; van Hoefen Wijsard M; van Leeuwen FE; Moll AC
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801943
[TBL] [Abstract][Full Text] [Related]
4. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.
Villanueva G; Sampor C; Moreno F; Alderete D; Moresco A; Pinto N; Szijan I; Schaiquevich P; Felice MS; Rose A; Zubizarreta P; Sgroi M; Fandiño A; Chantada G
Pediatr Blood Cancer; 2022 Aug; 69(8):e29710. PubMed ID: 35451226
[TBL] [Abstract][Full Text] [Related]
5. Benign Tumors in Long-Term Survivors of Retinoblastoma.
van Hoefen Wijsard M; Schonfeld SJ; van Leeuwen FE; Moll AC; Fabius AW; Abramson DH; Seddon JM; Francis JH; Tucker MA; Kleinerman RA; Morton LM
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917779
[TBL] [Abstract][Full Text] [Related]
6. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up.
Kleinerman RA; Tucker MA; Tarone RE; Abramson DH; Seddon JM; Stovall M; Li FP; Fraumeni JF
J Clin Oncol; 2005 Apr; 23(10):2272-9. PubMed ID: 15800318
[TBL] [Abstract][Full Text] [Related]
7. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
Schonfeld SJ; Kleinerman RA; Abramson DH; Seddon JM; Tucker MA; Morton LM
Br J Cancer; 2021 Mar; 124(7):1312-1319. PubMed ID: 33473166
[TBL] [Abstract][Full Text] [Related]
8. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.
Wong JR; Morton LM; Tucker MA; Abramson DH; Seddon JM; Sampson JN; Kleinerman RA
J Clin Oncol; 2014 Oct; 32(29):3284-90. PubMed ID: 25185089
[TBL] [Abstract][Full Text] [Related]
9. Retinoblastoma.
Lohmann D
Adv Exp Med Biol; 2010; 685():220-7. PubMed ID: 20687510
[TBL] [Abstract][Full Text] [Related]
10. Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot study.
Friedman DN; Lis E; Sklar CA; Oeffinger KC; Reppucci M; Fleischut MH; Francis JH; Marr B; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2014 Aug; 61(8):1440-4. PubMed ID: 24402721
[TBL] [Abstract][Full Text] [Related]
11. Sarcomas in hereditary retinoblastoma.
Kleinerman RA; Schonfeld SJ; Tucker MA
Clin Sarcoma Res; 2012 Oct; 2(1):15. PubMed ID: 23036192
[TBL] [Abstract][Full Text] [Related]
12. Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.
Friedman DN; Chou JF; Oeffinger KC; Kleinerman RA; Ford JS; Sklar CA; Li Y; McCabe MS; Robison LL; Marr BP; Abramson DH; Dunkel IJ
Cancer; 2016 Mar; 122(5):773-81. PubMed ID: 26755259
[TBL] [Abstract][Full Text] [Related]
13. [Molecular genetics and diagnosis of retinoblastoma. Significance for ophthalmologic practice].
Lohmann DR; Brandt B; Passarge E; Horsthemke B
Ophthalmologe; 1997 Apr; 94(4):263-7. PubMed ID: 9229493
[TBL] [Abstract][Full Text] [Related]
14. Variation of second cancer risk by family history of retinoblastoma among long-term survivors.
Kleinerman RA; Yu CL; Little MP; Li Y; Abramson D; Seddon J; Tucker MA
J Clin Oncol; 2012 Mar; 30(9):950-7. PubMed ID: 22355046
[TBL] [Abstract][Full Text] [Related]
15. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
17. RB1 germ-line deletions in Argentine retinoblastoma patients.
Fernández C; Repetto K; Dalamon V; Bergonzi F; Ferreiro V; Szijan I
Mol Diagn Ther; 2007; 11(1):55-61. PubMed ID: 17286450
[TBL] [Abstract][Full Text] [Related]
18. Tobacco use in adult long-term survivors of retinoblastoma.
Foster MC; Kleinerman RA; Abramson DH; Seddon JM; Tarone RE; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1464-8. PubMed ID: 16896033
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology of retinoblastoma.
Sábado Alvarez C
Clin Transl Oncol; 2008 Jul; 10(7):389-94. PubMed ID: 18628066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
